Language isn’t just a tool for communication. It is an instrument that can heal or harm. About 20 years ago, I learned this lesson the hard way. During a routine exam, I described a feline patient as “a bit pudgy” to the owner. The term felt harmless, and I was trying to be polite while discussing the cat’s obesity diagnosis. The consequences of minimizing the disease were significant. The owner dismissed my concerns and ignored the recommended therapeutic diet and weight loss plan. The cat later developed diabetes. For me, that outcome reinforced the power and peril of language softening in veterinary practice.
Today, the verbal stakes are higher than ever. Emerging research shows that stigmatizing language delays medical care, while precise terminology can improve patient outcomes.
When addressing obesity, veterinarians should practice clinical reframing. Moving away from casual labels like “chonky” and toward accurate medical terms such as “clinical obesity” is not about being harsh. It’s about being clear. That clarity is critical for effective treatment planning and for building lasting client trust.
The Problem with “Chonky”
Terms like “chonky,” “fluffy,” or “big-boned” are linguistic Band-Aids that cover the symptom while ignoring the disease. They risk labeling a serious medical condition as cute or inconsequential. Imagine calling a dog with heart failure “a little tired” or a cat with cancer “lumpy bumpy.” We would never trivialize those diseases, particularly in a clinical context.
Yet with pet obesity, we often soften the language and sidestep the diagnosis, despite abundant evidence that excess fat shortens life expectancy, causes chronic pain, and increases risk for diabetes, osteoarthritis, cancer, and organ failure, to name but a few proven comorbidities.
Calling a pet with obesity “chubby” is like calling diabetes a “little sugar issue.” It ignores rather than informs, masking a genuine medical risk and delaying appropriate treatment.
When it comes to pets, terms like “portly” or “big-boned” can function as a green light for inaction. Pet owners hear reassurance rather than risk. “He’s just a big boy” replaces “he’s at risk,” and the opportunity for early intervention is lost.
Language influences owner action because:
- Owners perceive “chonky” as endearing, not urgent. While humor can help open certain conversations, it can also unintentionally minimize medical risk and delay meaningful action by the pet owner and veterinary team.
- Delayed intervention worsens outcomes. The longer a pet carries excess fat, the greater the cumulative risk of metabolic disease, joint disease, and organ dysfunction. Long-term research shows that dogs with an overweight body condition have reduced life expectancy compared with dogs maintained at ideal body condition, with some breed-specific comparisons showing differences of up to about two-and-a-half years, depending on breed and degree of adiposity.
- Imprecise language affects diagnosis. When excess adiposity is downplayed or normalized, obesity can fade into the background rather than being addressed as a primary diagnosis, increasing the risk that related conditions are identified later or missed altogether.
The Problem with “Obese”
The adjective “obese” is often interpreted through a lens of blame. It is commonly associated with poor willpower or neglect, assumptions that modern science has clearly disproven.
Obesity is a multifactorial disease shaped by genetics, biology, environment, and behavior. In dogs, specific genetic variants influence obesity risk in certain breeds. A well-researched example is a deletion in the POMC gene associated with increased food motivation and adiposity in Labrador and flat-coated retrievers, while genome-wide studies have also identified variants such as DENND1B linked to increased body fat. In cats, obesity appears to reflect a more polygenic risk profile, with inherited susceptibility interacting with environmental factors such as indoor housing and feeding practices. Together, these findings reinforce that some pets are biologically predisposed to weight gain, underscoring that obesity is a disease, not a failure of willpower.
The problem arises when a patient’s biology is reduced to a static label rather than understood as part of a dynamic disease process shaped by genetics, physiology, environment, and behavior. When a pet is labeled “obese” without context, the diagnosis can feel like an indictment rather than a medical assessment, fostering avoidance, defensiveness, and distrust of veterinary recommendations.
Weight stigma is not merely uncomfortable. It is clinically consequential. In human medicine, patients who experience stigmatizing language are more likely to delay care, discontinue treatment, and experience worse physical and mental health outcomes. While direct parallels cannot be assumed, veterinary care similarly depends on owner interpretation and engagement, making language choice a key factor in whether care is proactive or delayed.
When obesity is framed in a way that feels accusatory or dismissive, owners are more likely to disengage. The result is not improved compliance, but delayed diagnosis and missed opportunities for early intervention.
Why “Clinical Obesity” Is Different
When I use the term clinical obesity, I’m not describing a pet’s appearance or assigning fault. I’m defining a disease state characterized by excess adiposity and measurable health consequences. That matters, because how we name a condition shapes how seriously it is taken.
The word obese often functions as an identity label. It can feel static, judgment-laden, and final. In contrast, clinical obesity frames the condition as a medical diagnosis with causes, progression, and treatment options. It shifts the conversation from what a pet is to what a pet has.
This framing creates clarity for everyone involved. It signals that obesity is not a cosmetic issue or a personal failure, but a treatable disease that deserves the same diagnostic rigor and therapeutic planning as diabetes, osteoarthritis, or heart disease.
Words shape how problems are understood and whether change feels possible. Identity-based labels such as “an obese dog” tend to imply a permanent state, where the condition becomes who the patient is rather than something the patient has. But person-first language, such as “a dog with clinical obesity,” separates the disease from the pet’s identity. It frames obesity as a medical condition that can be addressed, managed, and improved, rather than an inherent trait. That separation creates psychological space for action.
Instead of saying, “Your obese cat needs to lose weight,” try, “Your cat has clinical obesity, which we can manage together with a therapeutic nutrition and activity plan.”
This shift is more than semantics. It aligns with well-established behavior change models, which show that people are more likely to engage when a condition is presented as treatable, modifiable, and supported by a clear plan.
When clinical obesity is framed as a disease with management options, owners are more likely to participate, adhere, and return for follow-up, rather than disengage out of guilt or resignation.
In human health care, treating obesity as a primary disease has been shown to improve and, in some cases, induce remission of conditions such as Type 2 diabetes and cardiovascular disease. Addressing clinical obesity first:
- Reduces mechanical and metabolic stress
- Improves response to treatment for comorbidities
- Enhances lifespan and quality of life
Language plays a critical role in whether this approach is accepted or resisted.
A 7-year-old domestic shorthair with excess adiposity was affectionately called “tubby” by its owner and the veterinary team. Because the language felt benign, intervention was delayed. The cat later developed diabetes and osteoarthritis. When the diagnosis was reframed as clinical obesity, the owner recognized the urgency, began a therapeutic diet and targeted OA pain management, and later wished they had acted sooner.
Case 2: The “Fat-Shamed” Dachshund
An owner angrily left the practice after being told her dog was “a chonkster” and warned that he would “blow out his back.” When another veterinarian reframed the condition as clinical obesity with elevated risk of IVDD, trust was restored and care resumed.
Case 3: The “Snuffly” French Bulldog
Chronic respiratory noise had been normalized (“That’s just a chunky Frenchie!”) until excess adiposity was identified as a contributing factor to brachycephalic airway disease. Framing the diagnosis as “clinical obesity contributing to BOAS” prompted adherence to weight loss and surgical recommendations.
From “Obese” to “Clinical Obesity”
In 2025, The Lancet Diabetes & Endocrinology Commission on Clinical Obesity proposed a refined framework distinguishing excess adiposity alone as a risk state from clinical obesity, which it defined as excess adiposity accompanied by clinically meaningful impairment.
This framework is directly relevant to veterinary medicine. Following publication of The Lancet report, I co-wrote a Veterinary Record debate article calling for companion animal practice to adopt the same conceptual shift, distinguishing pets with excess adiposity and demonstrable clinical impairment from those with excess adiposity and elevated risk but no current obesity-related illness. Under this model, obesity exists along a continuum:
- Clinical obesity is excess adiposity that directly contributes to clinically meaningful impairment (e.g., reduced organ or tissue function, pain and mobility limitation, metabolic dysfunction, or measurable reduction in health-related quality of life).
- Pre-clinical obesity (risk state) is excess adiposity with preserved function, but with a substantially increased risk of progression to clinical obesity and other adiposity-related diseases.
This distinction matters. It moves obesity out of the realm of physical appearance and into the domain of disease diagnosis, clinical reasoning, and timely intervention.
The word “clinical” shifts obesity from a cosmetic observation to a medical condition. From non-urgent to actionable. From blame to biology. It signals that obesity:
- Can be diagnosed and staged clinically
- Requires veterinary oversight
- Deserves the same seriousness and urgency as other chronic diseases
Put simply, clinical obesity is not about how a pet looks. It is about how a pet functions. A practical way to conceptualize this is: clinical obesity equals excess adiposity plus measurable health impact.
This framework also supports earlier intervention. Pets across the obesity spectrum can be managed proactively, with therapeutic nutrition forming a foundation of care, reducing the likelihood that excess fat progresses to irreversible disease.
What This Looks Like in Practice
Consider two common clinical conversations:
The Blame Frame
Veterinarian: “Your dachshund is obese. You’re overfeeding her, and she needs more walks.”
Outcome: The owner feels blamed and judged. Follow-up appointments are canceled. Months later, the dog presents with an acute intervertebral disk episode requiring emergency surgery.
The Clinical Frame
Veterinarian: “Your dachshund has clinical obesity. The excess fat is increasing stress on her spine and raising her risk of disk injury. Let’s work together on a weight-loss plan that safely reduces fat while maintaining strength using a therapeutic diet.”
Outcome: The owner engages. Weight loss begins. Pain decreases, mobility improves, and follow-up visits continue.
The difference is not medical knowledge. It is language that clarifies risk without assigning fault.
Looking Ahead: Why Terminology Matters Now More Than Ever
As obesity care advances, diagnostic precision in veterinary medicine will continue to improve. Tools such as body composition assessment, wearable activity monitors, emerging biomarkers, and AI-assisted assessments are already expanding our ability to identify excess adiposity earlier and intervene more effectively.
At the same time, pharmacologic obesity treatments are no longer theoretical. Incretin-based approaches, including GLP-1-class candidates, are already in clinical study for companion animals. As these options evolve, consistent diagnostic language will be increasingly important, ensuring that veterinarians, care teams, and owners are aligned on the same disease state, risks, and treatment goals.
Labels like “chonky” and “obese” may seem harmless, but in clinical settings, they are often used subjectively and lack diagnostic clarity. When language trivializes risk or assigns blame, it undermines trust and delays care.
Pairing medically accurate terms, such as clinical obesity, with respectful language does more than improve conversations. It improves outcomes.
Clear language supports accurate diagnosis, appropriate treatment, and sustained client engagement. In veterinary medicine, language is part of the treatment plan.